ATOS
NASDAQ
$2.49
Atossa Therapeutics Inc (ATOS)
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $22 (+783.53%)
Market Cap
$21M
P/B Ratio
0.79
FCF 5Y CAGR
+21.22%
Beta (5Y)
1.32
Price Chart
Valuation
Market Cap$21M
Forward P/E7.04
P/S1872.06
P/B0.79
Profitability
EBITDA-$40M
EPS-$4.37
Growth & Risk
EPS 5Y CAGR+3.17%
FCF 5Y CAGR+21.22%
Beta (5Y)1.32
Sharpe Ratio-1.45